Nightingale receives CE marking for its at-home blood collection kit
Press release, 7 October 2021 at 9:30 a.m. (EEST) Nightingale Health Plc (“Nightingale”) has received a CE marking for its at-home blood collection kit that it uses in its at-home solution. The at-home blood collection kit is CE marked under the category of in vitro diagnostic medical devices, and the CE marking covers the packaging, the equipment used for the blood collection and instructions for use. Nightingale has previously distributed the at-home blood collection kit in its at-home pilot under the CE marking registered by the device manufacturer, but now the CE marking